دورية
Drug donated for treatment of visceral leishmaniasis.
العنوان: | Drug donated for treatment of visceral leishmaniasis. |
---|---|
المؤلفون: | Burki T |
المصدر: | The Lancet. Infectious diseases [Lancet Infect Dis] 2012 Feb; Vol. 12 (2), pp. 106-7. |
نوع المنشور: | News |
اللغة: | English |
بيانات الدورية: | Publisher: Elsevier Science Country of Publication: United States NLM ID: 101130150 Publication Model: Print Cited Medium: Internet ISSN: 1474-4457 (Electronic) Linking ISSN: 14733099 NLM ISO Abbreviation: Lancet Infect Dis Subsets: MEDLINE |
أسماء مطبوعة: | Original Publication: New York, NY : Elsevier Science ; The Lancet Pub. Group, 2001- |
مواضيع طبية MeSH: | Amphotericin B/*economics , Amphotericin B/*therapeutic use , Antiprotozoal Agents/*economics , Antiprotozoal Agents/*therapeutic use , Leishmania donovani/*isolation & purification , Leishmaniasis, Visceral/*drug therapy, Animals ; Charities ; Drug Industry/economics ; Humans ; Leishmaniasis, Visceral/economics ; Leishmaniasis, Visceral/microbiology |
التعليقات: | Erratum in: Lancet Infect Dis. 2012 Jun;12(6):429. |
المشرفين على المادة: | 0 (Antiprotozoal Agents) 0 (liposomal amphotericin B) 7XU7A7DROE (Amphotericin B) |
تواريخ الأحداث: | Date Created: 20120306 Date Completed: 20120503 Latest Revision: 20191112 |
رمز التحديث: | 20240513 |
DOI: | 10.1016/s1473-3099(12)70024-5 |
PMID: | 22389914 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1474-4457 |
---|---|
DOI: | 10.1016/s1473-3099(12)70024-5 |